These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17116636)

  • 1. [Factors associated with adherence to therapy among HIV-infected patients in Bangui].
    Mouala C; Kaba-Mebri J; Wata JB; Rey JL
    Sante; 2006; 16(2):119-30. PubMed ID: 17116636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measuring treatment compliance in patients with HIV in Bangui, Central African Republic].
    Mouala C; Kaba-Mebri J; Fikouma V; Wata JB; Gabrie P; Rey JL
    Med Trop (Mars); 2006 Feb; 66(1):59-63. PubMed ID: 16615617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M; Koffi CK
    AIDS; 2007 Aug; 21(13):1799-803. PubMed ID: 17690579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicines information and adherence in HIV/AIDS patients.
    Mansoor LE; Dowse R
    J Clin Pharm Ther; 2006 Feb; 31(1):7-15. PubMed ID: 16476115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda.
    Marseille E; Saba J; Muyingo S; Kahn JG
    AIDS; 2006 Apr; 20(6):907-14. PubMed ID: 16549976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of care.
    Herrmann S; McKinnon E; John M; Hyland N; Martinez OP; Cain A; Turner K; Coombs A; Manolikos C; Mallal S
    Intern Med J; 2008 Jan; 38(1):8-15. PubMed ID: 17916167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia.
    Beyene KA; Gedif T; Gebre-Mariam T; Engidawork E
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1007-15. PubMed ID: 19650153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance with cotrimoxazole prophylaxis for the prevention of opportunistic infections in HIV-positive tuberculosis patients in Thyolo district, Malawi.
    Zachariah R; Harries AD; Arendt V; Wennig R; Schneider S; Spielmann M; Panarotto E; Gomani P; Salaniponi FM
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):843-6. PubMed ID: 11573896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women.
    Vaz MJ; Barros SM; Palacios R; Senise JF; Lunardi L; Amed AM; Castelo A
    Int J STD AIDS; 2007 Jan; 18(1):28-32. PubMed ID: 17326859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing total health care costs and treatment patterns of HIV patients in a managed care setting.
    Purdum AG; Johnson KA; Globe DR
    AIDS Care; 2004 Aug; 16(6):767-80. PubMed ID: 15370064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
    J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 84-month follow up of adherence to HAART in a cohort of adult Senegalese patients.
    Etard JF; Lanièce I; Fall MB; Cilote V; Blazejewski L; Diop K; Desclaux A; Ecochard R; Ndoye I; Delaporte E;
    Trop Med Int Health; 2007 Oct; 12(10):1191-8. PubMed ID: 17956501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease progression in HIV-1 infected children and adolescents--results of a German-Austrian cohort study.
    Funk MB; Buchholz B; Notheis G; Neubert J; Feiterna-Sperling C; Ganschow R; Simon T; Hornemann F; Peters AM; Rütschle H; Horneff G; Lechner E; Hanschmann KM; Wintergerst U;
    Eur J Med Res; 2008 Aug; 13(8):371-8. PubMed ID: 18952519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership?
    Kremer H; Bader A; O'Cleirigh C; Bierhoff HW; Brockmeyer NH
    Eur J Med Res; 2004 Feb; 9(2):61-70. PubMed ID: 15090291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS.
    Garvie PA; Lensing S; Rai SN
    Pediatrics; 2007 Apr; 119(4):e893-9. PubMed ID: 17353298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia.
    Tadios Y; Davey G
    Ethiop Med J; 2006 Jul; 44(3):237-44. PubMed ID: 17447389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda.
    Bikaako-Kajura W; Luyirika E; Purcell DW; Downing J; Kaharuza F; Mermin J; Malamba S; Bunnell R
    AIDS Behav; 2006 Jul; 10(4 Suppl):S85-93. PubMed ID: 16791525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.
    Barfod TS; Sørensen HT; Nielsen H; Rodkjaer L; Obel N
    HIV Med; 2006 Jul; 7(5):285-90. PubMed ID: 16945072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the drug resources enhancement against AIDS and malnutrition program in Mozambique.
    San Lio MM; Carbini R; Germano P; Guidotti G; Mancinelli S; Magid NA; Narciso P; Palombi L; Renzi E; Zimba I; Marazzi MC
    Clin Infect Dis; 2008 May; 46(10):1609-16. PubMed ID: 18419498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.